Virax Biolabs Group Limited · NASDAQ:VRAX
Armistice Capital, LLC's stake in Virax Biolabs Group Limited fell to 4.99% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Armistice Capital, LLC's stake in Virax Biolabs Group Limited fell to 4.99%, 1,000,239 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 4.99%
- Shares
- 1,000,239
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 4.99% | 1,000,239 |
| Steven Boyd | 4.99% | 1,000,239 |
Source
Related
- Virax Biolabs Group Limited
- Armistice Capital, LLC
- Virax Biolabs Group Limited shareholders
- Schedule 13G · Armistice Capital, LLC · Feb 17, 2026
- Schedule 13G · James Foster · Oct 29, 2025
- Schedule 13G/A · James Foster · Oct 29, 2025
- Schedule 13G/A · James Foster · Oct 29, 2025
- Schedule 13G/A · James Foster · Oct 29, 2025